![Primary Care Initiation of Direct Oral Anticoagulants (DOACs) for Stroke Prevention in Atrial Fibrillation (AF) – GP Gateway Primary Care Initiation of Direct Oral Anticoagulants (DOACs) for Stroke Prevention in Atrial Fibrillation (AF) – GP Gateway](https://www.coventryrugbygpgateway.nhs.uk/wp-content/uploads/2019/10/VisionAF2.png)
Primary Care Initiation of Direct Oral Anticoagulants (DOACs) for Stroke Prevention in Atrial Fibrillation (AF) – GP Gateway
![Score de CHADS2 :évaluation du risque d'accident embolique cérébral chez un patient en fibrillation atriale - FMC DINAN Score de CHADS2 :évaluation du risque d'accident embolique cérébral chez un patient en fibrillation atriale - FMC DINAN](http://img.over-blog.com/600x398/0/10/54/33/2010/copieecran-2010-06-06-a-13.40.25.jpg)
Score de CHADS2 :évaluation du risque d'accident embolique cérébral chez un patient en fibrillation atriale - FMC DINAN
Prise en charge de la fibrillation auriculaire en médecine d'urgence Recommandations formalisées d'experts Société Fran
![COMORBIDITĂŢI ALE PACIENŢILOR V�RSTNICI CU FIBRILAŢIE ATRIALĂ NON-VALVULARĂ ŞI DECIZIA ANTICOLAGULĂRII PERMANENTE CU ANTIVITAMINE K �N PRACTICA MEDICALĂ CURENTĂ COMORBIDITĂŢI ALE PACIENŢILOR V�RSTNICI CU FIBRILAŢIE ATRIALĂ NON-VALVULARĂ ŞI DECIZIA ANTICOLAGULĂRII PERMANENTE CU ANTIVITAMINE K �N PRACTICA MEDICALĂ CURENTĂ](http://www.medicina-interna.ro/userfiles/Tabel1.jpg)
COMORBIDITĂŢI ALE PACIENŢILOR V�RSTNICI CU FIBRILAŢIE ATRIALĂ NON-VALVULARĂ ŞI DECIZIA ANTICOLAGULĂRII PERMANENTE CU ANTIVITAMINE K �N PRACTICA MEDICALĂ CURENTĂ
![Primary Care Initiation of Direct Oral Anticoagulants (DOACs) for Stroke Prevention in Atrial Fibrillation (AF) – GP Gateway Primary Care Initiation of Direct Oral Anticoagulants (DOACs) for Stroke Prevention in Atrial Fibrillation (AF) – GP Gateway](https://www.coventryrugbygpgateway.nhs.uk/wp-content/uploads/2019/10/CHADSVASC-revised-png.png)
Primary Care Initiation of Direct Oral Anticoagulants (DOACs) for Stroke Prevention in Atrial Fibrillation (AF) – GP Gateway
![CHADS 2 -> CHA 2 DS 2 VASc. CHA2DS2-VASc Risk Score CHF or LVEF < 40% 1 Hypertension1 Age > 752 Diabetes1 Stroke/TIA/ Thromboembolism 2 Vascular Disease. - ppt download CHADS 2 -> CHA 2 DS 2 VASc. CHA2DS2-VASc Risk Score CHF or LVEF < 40% 1 Hypertension1 Age > 752 Diabetes1 Stroke/TIA/ Thromboembolism 2 Vascular Disease. - ppt download](https://images.slideplayer.com/30/9547440/slides/slide_3.jpg)
CHADS 2 -> CHA 2 DS 2 VASc. CHA2DS2-VASc Risk Score CHF or LVEF < 40% 1 Hypertension1 Age > 752 Diabetes1 Stroke/TIA/ Thromboembolism 2 Vascular Disease. - ppt download
![Pour en savoir plus sur l'estimation de la balance bénéfices/risques avec les AOD [Prévenir les erreurs liées aux médicaments Anticoagulants Oraux Directs - "Never Events AOD"] Pour en savoir plus sur l'estimation de la balance bénéfices/risques avec les AOD [Prévenir les erreurs liées aux médicaments Anticoagulants Oraux Directs - "Never Events AOD"]](http://www.omedit-centre.fr/AOD/res/score_chadsvasc.jpg)
Pour en savoir plus sur l'estimation de la balance bénéfices/risques avec les AOD [Prévenir les erreurs liées aux médicaments Anticoagulants Oraux Directs - "Never Events AOD"]
Prise en charge du risque thrombotique lié à la fibrillation auriculaire (FA) chez des patients âgés en ambulatoire: état d
![CHADS 2 -> CHA 2 DS 2 VASc. CHA2DS2-VASc Risk Score CHF or LVEF < 40% 1 Hypertension1 Age > 752 Diabetes1 Stroke/TIA/ Thromboembolism 2 Vascular Disease. - ppt download CHADS 2 -> CHA 2 DS 2 VASc. CHA2DS2-VASc Risk Score CHF or LVEF < 40% 1 Hypertension1 Age > 752 Diabetes1 Stroke/TIA/ Thromboembolism 2 Vascular Disease. - ppt download](https://images.slideplayer.com/30/9547440/slides/slide_2.jpg)